Company for sale
- Size: Mid
- Revenue: >15M Euro
- Location of the company: Western Europe
- CFIE PHS116
Overview of Phase 1 CRO in Western Europe for sale
This well-established Contract Research Organization (CRO) is a leading provider of early phase clinical research services with a longstanding presence in the healthcare industry. With a legacy rooted in clinical pharmacology and over four decades of collective expertise, the company is dedicated to advancing the development of new drugs that enhance patient outcomes. It is recognized as a trusted partner for biopharmaceutical and healthcare companies seeking excellence in early clinical development.
Profile of Phase 1 CRO in Western Europe for sale
Formed through the strategic merger of several reputable CROs, the organization operates multiple state-of-the-art Clinical Pharmacology Units (CPUs). Its facilities are equipped to support a broad range of early phase trials, offering comprehensive infrastructure and a specialized focus on First-in-Human (FIH) and Proof-of-Concept (PoC) studies. The company has built a strong reputation across the industry, known for its scientific rigor, operational efficiency, and tailored approach to client needs.

Subscribe for similar companies for sale
Subscribe now and we will inform you when similar companies for sale come up!
Activity and Products of Phase 1 CRO in Western Europe for sale
The company provides full-service support for early phase clinical trials, ranging from healthy volunteer studies to patient-centric and multicenter trials. Its core therapeutic areas of expertise include metabolic and cardiovascular disorders, women’s health, and trials involving renally and hepatically impaired patients. Services include standard PK/PD trial designs, as well as complex Phase I studies, making it a go-to partner for both strategic and tactical outsourcing in drug development. The organization also serves clients across diverse sectors, including pharmaceuticals, biotechnology, nutritional products, medical devices, and cosmetics.
Highlights of Phase 1 CRO in Western Europe for sale
- Deep specialization in early phase clinical research with a strong emphasis on innovation and regulatory compliance.
- Proven experience in complex clinical trial designs and patient-specific studies.
- Strong track record of successful partnerships with a diverse client base across healthcare-related industries.
- Fully equipped clinical research infrastructure with high capacity, enabling flexibility and scalability.
- Expert knowledge in guiding clients through the intricacies of early drug development, from FIH to PoC.
- Positioned among Europe’s leading Phase I service providers with a reputation for excellence and reliability.
More information on this phase 1 CRO in Western Europe for sale
Please get in touch if you are interested in learning more about this phase 1 CRO in Western Europe for sale. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.
Subscribe as an interested buyer for similar companies for sale
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.